Kamron Laboratories Ltd. announced standalone unaudited earnings results for the third quarter and nine months ended December 31, 2019. For the quarter, the company reported revenue from operation of INR 17.892 million compared to INR 10.838 million a year ago. Loss for the period from continuing operation was INR 20.412 million compared to INR 3.066 million a year ago. Loss for the period was INR 20.412 million compared to INR 3.066 million a year ago. Loss per share (for discontinued and continuing operation) was INR 0.35. For the nine months, the company reported revenue from operation of INR 52.203 million compared to INR 45.458 million a year ago. Loss for the period from continuing operation was INR 30.38 million compared to INR 18.049 million a year ago. Loss for the period was INR 30.380 million compared to INR 18.049 million a year ago. Loss per share (for discontinued and continuing operation) was INR 0.52.